Bank Julius Baer & Co. Ltd, Zurich Leap Therapeutics, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$1.35 - $4.01 $6,585 - $19,560	-4,878 Closed	0 $0
Q2 2021 Jul 23, 2021	SELL	$1.48 - $1.92 $180 - $234	-122 Reduced 2.44%	4,878 $8,000
Q1 2021 May 10, 2021	BUY	$1.82 - $3.01 $202 - $334	111 Added 2.27%	5,000 $9,000
Q4 2020 Feb 24, 2021	BUY	$1.49 - $2.37 $7,034 - $11,188	4,721 Added 2810.12%	4,889 $11,000
Q4 2020 Feb 12, 2021	SELL	$1.49 - $2.37 $7,199 - $11,451	-4,832 Reduced 96.64%	168 $11,000
Q3 2020 Nov 10, 2020	BUY	$1.68 - $2.17 $8,400 - $10,850	5,000 New	5,000 $10,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $344M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.